Franklin Resources Inc Exelixis, Inc. Transaction History

Franklin Resources Inc

$330 Billion
Q1 2025

A detailed history of Franklin Resources Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,245,545 shares of EXEL stock, worth $52.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,245,545

Previous 891,985 39.64%

Holding current value

$52.8 Million

Previous $29.7 Million 54.82%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$32.38 - $39.16 $11.4 Million - $13.8 Million	353,560 Added 39.64%	1,245,545 $46 Million
Q4 2024 Feb 12, 2025	BUY	$25.39 - $36.46 $2.47 Million - $3.55 Million	97,342 Added 12.25%	891,985 $29.7 Million
Q3 2024 Nov 12, 2024	SELL	$21.96 - $27.6 $1.6 Million - $2.01 Million	-72,798 Reduced 8.39%	794,643 $20.6 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $106,113 - $123,799	5,217 Added 0.61%	867,441 $19.5 Million
Q1 2024 May 13, 2024	BUY	$20.17 - $23.93 $8.63 Million - $10.2 Million	427,753 Added 98.45%	862,224 $20.5 Million
Q4 2023 Feb 09, 2024	BUY	$19.25 - $24.13 $1.6 Million - $2 Million	82,916 Added 23.59%	434,471 $10.4 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $4.27 Million - $5.09 Million	224,005 Added 175.62%	351,555 $7.68 Million
Q2 2023 Aug 11, 2023	BUY	$18.17 - $20.48 $579,459 - $653,127	31,891 Added 33.34%	127,550 $2.44 Million
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $121,418 - $144,585	-7,449 Reduced 7.22%	95,659 $1.86 Million
Q4 2022 Feb 10, 2023	SELL	$14.96 - $17.39 $2.21 Million - $2.56 Million	-147,493 Reduced 58.86%	103,108 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $3.68 Million - $5.23 Million	234,652 Added 1471.26%	250,601 $3.93 Million
Q2 2022 Aug 11, 2022	SELL	$17.44 - $23.16 $173,929 - $230,974	-9,973 Reduced 38.47%	15,949 $331,000
Q1 2022 May 13, 2022	SELL	$17.03 - $22.67 $78,610 - $104,644	-4,616 Reduced 15.12%	25,922 $589,000
Q4 2021 Feb 11, 2022	BUY	$15.84 - $21.88 $9,218 - $12,734	582 Added 1.94%	30,538 $558,000
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $138,501 - $179,626	-8,497 Reduced 22.1%	29,956 $634,000
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $1.23 Million - $1.76 Million	-68,721 Reduced 64.12%	38,453 $700,000
Q1 2021 May 13, 2021	SELL	$20.53 - $25.22 $170,891 - $209,931	-8,324 Reduced 7.21%	107,174 $2.42 Million
Q4 2020 Feb 10, 2021	SELL	$18.39 - $24.8 $953,098 - $1.29 Million	-51,827 Reduced 30.97%	115,498 $2.32 Million
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $231,855 - $302,185	-11,217 Reduced 6.28%	167,325 $4.09 Million
Q2 2020 Aug 13, 2020	SELL	$16.46 - $27.42 $78,431 - $130,656	-4,765 Reduced 2.6%	178,542 $4.44 Million
Q1 2020 May 13, 2020	BUY	$14.46 - $21.8 $284,081 - $428,282	19,646 Added 12.0%	183,307 $3.16 Million
Q4 2019 Feb 12, 2020	BUY	$15.15 - $18.89 $554,050 - $690,826	36,571 Added 28.78%	163,661 $2.88 Million
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $705,750 - $904,142	39,918 Added 45.79%	127,090 $2.25 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $572,613 - $748,662	30,249 Added 53.14%	87,172 $1.86 Million
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $13.8 Million - $17.4 Million	-701,583 Reduced 92.5%	56,923 $1.35 Million
Q4 2018 Feb 12, 2019	SELL	$13.65 - $21.8 $17.2 Million - $27.5 Million	-1,261,134 Reduced 62.44%	758,506 $14.9 Million
Q3 2018 Nov 13, 2018	SELL	$15.87 - $22.4 $3.02 Million - $4.27 Million	-190,510 Reduced 8.62%	2,019,640 $35.8 Million
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $1.4 Million - $1.69 Million	75,209 Added 3.52%	2,210,150 $47.6 Million
Q1 2018 May 10, 2018	SELL	$22.15 - $31.89 $5.1 Million - $7.35 Million	-230,330 Reduced 9.74%	2,134,941 $47.3 Million
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $3.55 Million - $4.53 Million	-146,529 Reduced 5.83%	2,365,271 $71.9 Million
Q3 2017 Nov 13, 2017	BUY	$23.35 - $29.24 $58.7 Million - $73.4 Million	2,511,800	2,511,800 $60.9 Million

Others Institutions Holding EXEL

# of Institutions

613

Shares Held

257M

Call Options Held

1.57M

Put Options Held

730K

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $13.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Exelixis, Inc. Transaction History